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Kinesins are a superfamily of microtubule-based molecular motors that perform various transport needs
and have essential roles in cell division. Among these, the kinesin-5 family has been shown to play a major
role in the formation and maintenance of the bipolar mitotic spindle. Moreover, recent work suggests that
kinesin-5 motors may have additional roles. In contrast to most model organisms, the sole kinesin-5 gene in
Caenorhabditis elegans, bmk-1, is not required for successful mitosis and animals lacking bmk-1 are viable
and fertile. To gain insight into factors that may act redundantly with BMK-1 in spindle assembly and to
identify possible additional cellular pathways involving BMK-1, we performed a synthetic lethal screen using
the bmk-1 deletion allele ok391. We successfully knocked down 82% of the C. elegans genome using RNAi
and assayed viability in bmk-1(ok391) and wild type strains using an automated high-throughput approach
based on ﬂuorescence microscopy. The dataset includes a ﬁnal list of 37 synthetic lethal interactions whose
further study is likely to provide insight into kinesin-5 function.
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Background & Summary
The mitotic spindle consists of microtubule ﬁlaments that are organized into a bipolar conﬁguration by a
variety of microtubule-associated proteins (MAPs) and their regulators. Of the MAPs with motor activity,
members of the kinesin-5 family play a central role. With four identical motor domains conﬁgured like a
‘dumbbell’1, kinesin-5 is capable of cross-linking and sliding apart antiparallel microtubules2, thereby
generating an outward force on the spindle. In mammals, kinesin-5 is essential to separate centrosomes
early in mitosis to form the bipolar spindle3, while in S. cerevisiae and Drosophila S2 cells kinesin-5
activity is used later in mitosis to elongate the anaphase spindle4,5. By contrast, the C. elegans kinesin-5
homolog BMK-1 acts as a break for spindle elongation in anaphase of the ﬁrst embryonic division6. In
this context, the cross-linking activity of BMK-1 likely resists the strong cortical forces in the one-cell
embryo that pull the two spindle poles apart. Thus, while sequence conservation suggests that the basic
activity of kinesin-5 is the same in all species, considerable variation exists in the requirement for this
activity in mitosis. In addition, the dispensability of kinesin-5 for successful mitosis in C. elegans may hint
at redundant mechanisms for spindle assembly in this organism.
Several lines of evidence suggest that kinesin-5 also has multiple roles beyond mitosis. Mammalian
Eg5 is a regulator of axonal growth7,8 and has been shown to associate with ribosomes to enhance the
efﬁciency of translation9, while C. elegans BMK-1 was identiﬁed in a genome-wide screen for genes that
regulate germ cell apoptosis10.
To gain insight into factors that may act redundantly with kinesin-5 in spindle assembly in C. elegans
and to uncover possible additional functions of kinesin-5, we conducted a genome-wide synthetic lethal
RNAi screen using animals harbouring the genetic deletion allele bmk-1(ok391). The viability and fertility
of bmk-1(ok391) animals is indistinguishable from wild type controls, making this genetic background
ideal for a synthetic lethal screen. Knockdown by RNAi was carried out by bacterial feeding using the
Ahringer genome-wide library11 adapted to a 96-well liquid format. We marked animals with green
ﬂuorescent protein in the pharynx (myo-2::gfp) for detection and accurate counting with an automated
ﬂuorescence microscopy system, in which adult worms (parents) and larvae (progeny) could be
distinguished by the size of their pharynx. This allowed determination of ‘reproductive ﬁtness’, deﬁned as
the number of progeny per parent. The primary screen consisted of two technical replicates per bacterial
clone (16757 clones) expressing a gene-speciﬁc dsRNA. Genes that when knocked down signiﬁcantly
decreased reproductive ﬁtness in bmk-1(ok391) animals relative to control animals were considered hits.
These were selected for secondary screening (Fig. 1), which consisted of 3 biological replicates, each
carried out in 2 technical replicates. Data analysis and validation steps generated a list of 37 genes that
display synthetic lethality with bmk-1(ok391) (Data Records 1 and 2). The list contains genes implicated
in both embryonic and post-embryonic development (Table 1).
The RNAi dataset presented here points to cellular pathways beyond spindle assembly in which
C. elegans kinesin-5 might play a role. Furthermore, the data on reproductive ﬁtness in the wild type
strain N2 may serve as a useful reference for other genome-wide RNAi screens in C. elegans. Finally, we
hope that our adaptation of 96-well liquid format screening12 to an automated pipeline with a microscope
image-based read-out will encourage others to execute similar large-scale screens using this approach.
Methods
Strains and culture
Worms were cultured on nematode growth media (NGM) plates seeded with OP50 bacteria. Strains used
in this study include: N2 wild type Bristol variant, SV1005 bmk-1(ok391) V backcrossed 8 times with N2,
SV1069 myo-2::GFP backcrossed 4 times with N2 and SV1070 myo-2::GFP; bmk-1(ok391) V from
crossing SV1005 with SV1069. Worm strains were grown at 16 or 20 °C. Newly generated strains will be
donated and available through the Caenorhabditis Genetics Center (CGC).
High throughput RNA interference screening
Methodology overview. To perform the genome-wide RNA interference (RNAi) screen we devised an
automated screening platform, based on a previously developed protocol for C. elegans screening in liquid
culture using 96-well plates12. We used synchronized ﬁrst larval stage (L1) animals, which we fed with
bacteria from the C. elegans RNAi feeding library constructed by the Ahringer group11. We compared the
viability of progeny from control and bmk-1(ok391) parents following feeding with bacteria expressing
gene-speciﬁc double-stranded RNA (dsRNA). For each 96-well library plate with bacteria, we assayed two
technical replicates per strain as well as negative and positive controls, positioned in column 1 (wells A1
to H1). The negative controls were empty feeding vector (L4440, a gift from Andrew Fire (Addgene
plasmid # 1654)) and hil-5 dsRNA that exhibit no lethality. plk-1 dsRNA, which causes 100% embryonic
lethality, was used as a control for RNAi, and dli-1 dsRNA was used as a control for enhanced lethality
speciﬁcally in the bmk-1(ok391) background (hereafter referred to as positive control). Worm strains
SV1069 and SV1070 express green ﬂuorescent protein (GFP) in the pharynx from the myo-2 promoter,
which allowed image acquisition and worm counting with an automated ﬂuorescence microscope
(Thermo ArrayScan VTi) (Fig. 1a). All liquid dispensing steps were carried out with the Sciclone ALH
3000 liquid handling robot (Caliper Lifesciences). L1 larvae were dispensed into each well of 96-well
plates, using a MultidropTM Combi Reagent Dispenser (Thermo Scientiﬁc). For the secondary screen,
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bacterial clones that enhanced lethality above a certain threshold (see below) were re-assayed in three
biological replicates using the same experimental procedure of the primary screen, (Fig. 1b).
Screening reagents
● Ahringer RNAi feeding library with 16757 bacterial clones11 (Source BioScience, Nottingham, GB)
● LB (Luria-Bertani) media plus 100 μg ml− 1 Ampicillin and 12,5 μg ml− 1 Tetracyclin hydrocloride
● NGM agar plates seeded with Escherichia coli OP50 (available from the C. elegans Genetics center) for
growing worms
● IPTG 4 mM to induce lac operon controlled gene expression in bacteria
● M9 buffer
C. elegans RNAi feeding library 
targeting 16757 genes
Synchronized L1 worms
SV1070 
(bmk-1 ok391)
SV1069
(wild type)
4 days 20°C 200rpm
Imaging and worms counting
Determination of 
Reproductive Fitness ratio
≤0.5 ≥1.5 
Supressor
>0.5<1.5 
No effect Enhancer
Visual inspection of the data
Secondary Screen
Figure 1. Experimental workﬂow. (a) Example of a mosaic reconstruction of an imaged well of the screen. In
the magniﬁcation of ﬁeld 2, the white arrowhead shows the pharynx of a parent worm, blue arrowheads show
pharynxes of progeny, and the orange arrowhead points to excluded objects. Scale bar is 150 μm. (b) Flowchart
of screening protocol. The primary screen was done in two technical replicates. The secondary screen followed
the same protocol as the primary screen but used three biological replicates with two technical replicates each.
www.nature.com/sdata/
SCIENTIFIC DATA | 2:150020 | DOI: 10.1038/sdata.2015.20 3
● Complete S medium plus 10 ml l− 1 Penicillin-Streptomycin and 50 mg l− 1 Nystatin
● Bleach solution (10 M NaOH, 4% sodium hypochlorite)
● Tween 20 (P2287, Sigma-Aldrich)
● Tricaine (E10521, Sigma-Aldrich)
● Tetramisole hydrochloride (T1512, Sigma-Aldrich)
hit plate well Cosmid(s) Primary targets Secondary
targets
Gene(s) name(s) N2 (wild type) SV1005 (kinesin-5
mutant)
Embryonic Post-embryonic Embryonic Post-
embryonic
1 B08 R06C7.10 myo-1 Gro Gro
1 B11 F36H2 F36H2.1 tat-5 Emb Emb
1 C09 C39E9+B0564 C39E9.14 dli-1 Emb Adl+Ste+Bag Emb Ste+Pvl
1 C11 F46A9+F30A10 F46A9.4 F46A9.5 skr-2+skr-1 Gro Gro
1 D05 W09C3+T03F1 W09C3.6 T03F1.5 gsp-3+gsp-4 Gro Gro
1 D07 W01A8 W01A8.4 nuo-6 Lva Lva
1 D11 C17E4 C17E4.5 pabp-2 Gro+Lva Gro+Lva
1 E11 C41G7+M01E11 C41G7.2 M01E11.6 klp-16+klp-15 Emb Gro Emb Gro
2 B11 T26E3 T26E3.3 par-6 Emb Ste Emb Ste
2 E11 T08B2 T08B2.8 T08B2.7 mrpl-23+ech-1.2 Gro Gro
3 C04 F26E4 F26E4.8 tba-1 Emb Emb
3 C10 Y71F9AM Y71F9AM.4 Y71F9AM.7 cogc-3+Y71F9AM.7 Ste+Sck Ste+Sck
3 F11 F52C6+M7 M7.1 F52C6.12 ubc-2(let-70)
+F52C6.12
Emb no defect Emb no defect
4 E05 F37C12 F37C12.3 F37C12.3 Gro Gro
4 E08 B0285 B0285.1 cdtl-7 Lva Lva
4 F03 T12G3 T12G3.5 mrpl-51 Gro+Lva Gro+Lva
4 H05 B0280 B0280.9 B0280.9 Gro+Ste+Sck Gro+Ste+Sck
5 C11 W09H1+several
other
several his- genes Emb Emb
5 F02 F09E5 F09E5.1 pkc-3 Emb Emb
5 F08 Y49E10+Y51H7C
+ Y9D1A
+Y46H3C+etc
Gro Gro
6 C03 several F54D5.11 T01G5.8 Emb Gro+Rup Emb Gro+Rup+Pat
6 C06 F01F1 F01F1.7 ddx-23 Emb Lva Emb Lva
6 C09 F58A4 F58A4.8 tbg-1 Emb Ste+Pvl Emb
6 D07 Y43C5A Y43C5A.6 rad-51 no defect no defect
7 A10 H06I04 H06I04.3 H06I04.3 Gro Gro+Ste
7 E09 M04D8 M04D8.6 xbx-3 no defect
7 H04 F42A8+C06C3 C06C3.1 mel-11 Adl+Ste+Bag Ste+Sck
7 H12 E04A4 E04A4.7 cyc-2.1 Gro Lva
8 A02 K08F11 K08F11.4 yars-1 Gro Gro+Lva
9 H10 YAC Y38F2AL Y38F2AL.4 vha-3 Lva >Gro
9 H12 Y6E2A Y6E2A.9 sfxn-1.3 Gro+Lva no defect
11 B02 Y82E9BR Y82E9B5.3 Y82E9BR.3
+Y82E9BR.27
+Y82E9BR.30
Gro >Gro
11 B07 F26H11 F26H11.1 kbp-3 (knl) Emb Ste Emb Ste+Adl+Gro
+Pvl
11 D03 F11A3+C50F4 F11A3.2 F11A3.2 Gro Ste+Lva
12 H02 T27B1 T27B1.2 ztf-19/pat-9 Emb Emb Pat+Adl+Rup
+Dpy
12 F04 T27B1 T27B1.2 ztf-19/pat-9 Emb Ste+Sck Emb
13 D05 F25G6 F25G6.2 symk-1 Emb no defect Emb Gro+Sck+Adl
13 H02 F49C12 F49C12.13 vha-17 Gro
Table 1. Final hit list. Table summarizing the genes that genetically interact with the worm kinesin-5 and the
observed developmental defects upon dsRNA treatment. Description of the abbreviations can be found at
www.RNAi.org15.
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Day 1: RNAi library replication
The 96-well RNAi library plates with bacterial glycerol stocks and the microtiter plates with controls were
thawed at room temperature for 10 min prior to use. A 96-pin replicator (BOEKEL), with the ﬁrst
column of pins removed, was used to inoculate 100 μl of LB (supplemented with Ampicillin and
Tetracyclin hydrocloride) in each well of a new 96-well plate with bacteria. Positive and negative controls
were then added to the ﬁrst column in each 96-well plate. The ﬁrst column of every library plate was
replicated into a separate 96-well plate for screening. Bacteria were grown overnight (ON) at 37 °C.
Day 2: Preparation of bacteria and worms
5 μl of the bacterial ON cultures were used to inoculate 400 μl of LB (supplemented with Ampicillin and
Tetracyclin hydrocloride) in a 2-ml 96-well plate, followed by ON incubation in a shaking incubator at
220 r.p.m. at 37 °C. Gravid adult worms were washed off NGM agar plates in M9 buffer, pelleted by
centrifugation for 1 min at 1,350 r.p.m. and subjected to bleach solution for 5–10 min with occasional
vortexing until only embryos remained. Embryos were pelleted by centrifugation for 1 min at 1,350 r.p.m.
and resuspended in M9 buffer three times to remove bleach. Embryos were allowed to hatch ON in M9
buffer in a shaking incubator at 200 r.p.m. at 20 °C.
Day 3: RNAi feeding
L1 worms were resuspended at a concentration of approximately seven larvae per 10 μl of M9 buffer.
Tween 20 was added to the worms to a ﬁnal concentration of 0,01% to avoid worms sticking to the plastic
tubing during dispensing. IPTG was added to each well of the bacterial cultures to a ﬁnal concentration of
4 mM to induce dsRNA transcription during 1 h incubation at 37 °C. Bacteria was then pelleted by
spinning at 4,000 r.p.m. for 5 min and subsequently resuspended in 400 μl of Complete S medium plus
4 mM IPTG. 40 μl of each bacterial culture were transferred to ﬂat-bottomed 96-well plates followed by
10 μl of M9 buffer containing the L1 worms. The plates were incubated at 20 °C for 4 days with shaking at
200 r.p.m., allowing sufﬁcient time for the L1 worms to grow to adults and lay eggs, and for the eggs to
hatch and develop into larvae.
Day 7: Phenotype scoring
Prior to image acquisition, 70 μl of worm paralyzing solution (50 μl of complete S medium and 20 μl of
0,7% Tricaine+0,07% Tetramisole) was added to all wells. We imaged the entire well (25 ﬁelds per well
with a 20x objective) and counted the number of adult worms (parents, bigger pharynxes) and the
number of larvae (progeny, smaller pharynxes) using the Cellomics® Target Activation BioApplication
(Fig. 1a, magniﬁcation).
Data collection and analysis
Quantiﬁcation of number of adults. Automated image analysis was performed and the number of
parent worms, which correspond to the number of L1s dispensed on day 3, was determined. Only wells
with 2–12 parent worms were considered for further analysis, as the number of obtained progeny within
this range is linear (Fig. 2a, top graph).
Determination of reproductive ﬁtness ratio. Reproductive Fitness (RF) is deﬁned as the number of
progeny per parent worm treated with dsRNA. It was obtained by dividing the total number of viable
progeny by the number of parents for each experimental well. The Reproductive Fitness ratio (RFratio)
was obtained dividing the RF of the control strain (SV1070) by the RF of the bmk-1(ok391) strain
(SV1069) (Fig. 2a, bottom graph).
Data import, management, quality assessment and replicate summarization. Raw data, i.e., the
RF for each targeted gene in the two strains, was analyzed using the software package cellHTS2 (ref. 13)
implemented in Bioconductor/R. Normalization to correct for plate effects was performed by dividing
each measurement by the median value across the ‘sample’ wells in each plate.
Hits selection. Primary screen. Upon determination of the RFratios, we continued with genes whose
depletion led to minimally a 50% increased lethality in SV1070 when compared to SV1069 (RFratio≤ 0.5)
(Fig. 2b). Upon visual inspection of the data, we also included genes whose depletion led to a signiﬁcant
(RFratio≥ 1.5) reduction in lethality in SV1070 when compared to SV1069. Targeted genes resulting in
more than 90% lethality in the control strain were excluded, since the RFratio would be unreliable. In total
1,057 bacterial clones were selected for the secondary screen (575 enhancers and 482 suppressors) (Data
Record 1).
Hits selection. Secondary screen. Using the RFratio of the positive and negative controls, we
determined the percentage of expected false positives and false negatives for cut-offs ranging from
40–70%. We decided to continue with bacterial clones showing a minimum increase in lethality of 45% in
SV1070 when compared with SV1069 (RFratioo0.55), since this predicts a similar percentage of false
positive and false negative results across three biological replicates. 168 bacterial clones classiﬁed as hits
under this criterion (Fig. 2c) (Data Record 2). Next, we built a Venn diagram with the three sets of hits
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from the three independent experiments and accepted as ﬁnal hits genes that classiﬁed as enhancers in at
least two out of the three independent experiments (Fig. 2d). All targeting vectors from the ﬁnal hit list
were sequenced in order to conﬁrm the identity of the targeted gene (Table 1).
Data Records
The raw and analyzed data produced by this screen are formatted as two downloadable spreadsheets from
FigShare (Data Citation 1).
Data record 1—primary screen
Primary dsRNA screen data are contained in tabs termed Controls (negative and positive controls),
Samples (RNAi vectors) and ND Samples (targeting sequences for which an RFratio could not be
determined for technical reasons). The tab termed ‘Selection 2nd Screen’ contains all the targeting
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Figure 2. Genome-wide RNAi screen results. (a, top) Determination of the ideal number of parents per well.
Between 2 and 12 the number of obtained progeny is linear. Wild type strain is myo-2::GFP. bmk-1(ok391);
myo-2::GFP is the mutant strain. (a, bottom) RFratio calculation and distribution of worms treated with an
empty RNAi vector. Error bars represent SEM of three biological replicates, each containing two technical
replicates. (b) Primary screen results. RFratio distribution of screen controls and library RNAi vectors. Dashed
lines represent the thresholds for the deﬁnition of ‘enhancers’ (o0.5) and ‘suppressors’ (>1.5). Percentages
represent the total number of negative (grey) and positive (orange) controls within each cut-off range. Total
number of library RNAi vectors in each category is also represented by percentages (green). (c) Secondary
screen results. RFratio distribution of each control or library RNAi vector across three biological replicates.
Dashed line indicates the threshold value below which we considered the RNAi to ‘enhance’ bmk-1(ok391).
Percentages represent the total number of negative controls (empty vector, hil-5 dsRNA, in dark grey), positive
controls (orange) and library RNAi vectors (green) in each category. (d) Venn diagram showing the common
and unique hits found within the biological replicates. 38 targeting sequences classify as ‘enhancers’ in at least
two out of the three replicates.
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sequences taken to the secondary screen and respective location coordinates in the arrayed hit plates
(1–13).
Information regarding the column headings:
Plate. Ahringer library plate number.
Well. Well coordinates.
Description. Content description. ‘sample’, RNAi vector. ‘neg’, negative control. ‘pos’, positive control.
‘other’, embryonic lethality control.
GeneID. Gene sequence identiﬁcation number/name.
Raw_r1/r2_. Raw data value for technical replicate 1 or 2 for each assayed worm strain.
RF (AVG replicates). Average (arithmetic mean) Reproductive Fitness of replicates. Sometimes the RF
of one of the two replicate could not be determined for technical reasons. In these cases the RF value
corresponds to the RF of the single replicate that worked.
RFratio. Obtained dividing the RF (AVG replicates) of SV1070 by the RF (AVG replicates) of SV1069.
Classiﬁcation. Controls or Samples are classiﬁed as ‘enhancer’ if RFratio is ≤0.5, ‘suppressor’ if RFratio is
≥1.5, otherwise ‘no effect’.
Data record 2—secondary screen
Secondary dsRNA screen data are included under different tabs of the spreadsheet. Content description
and column details are given below:
‘Total data’. Contains the raw values and calculated RFratios for every experimental well of the three
independent experiments. Column headings are the same as in Data Record 1.
‘Controls’. The RFratio for the negative and positive controls from the previous sheet was calculated for
each experiment. Next, we classiﬁed each result as ‘enhancer’, ‘no effect’ or ‘suppressor’ applying different
cut-offs (40%, 45%, 50%, 55%, 60%, 65%, 70%) to the RFratios. We then determined the predicted
percentage of false positive and false negative results for each cut-off. To generate the ﬁnal hit list, we
used a 45% cut-off, which predicted a similar percentage of false positive and false negative results across
the three independent experiments.
‘Samples’ (45%). RFratio for each RNAi vector was extracted from the ‘Total data’ sheet and classiﬁed
as ‘enhancer’, ‘no effect’ or ‘suppressor’ according to a 45% cut-off. Cells in red correspond to targeting
sequences classifying as ‘enhancers/suppressors’ in the three independent experiments. Cells in orange
correspond to targeting sequences classifying as ‘enhancers/suppressors’ in two out of the three
independent experiments. ‘suppressors’ were not taken into consideration for further analysis, since they
were not the aim of this screen. Nevertheless, they might represent a suppression of a RNAi phenotype by
the bmk-1 loss of function.
Technical Validation
Technical and biological replicates
It was not possible to do the primary screen in multiple biological replicates due to the high cost and
logistic challenges. Therefore, we used two technical replicates. For the secondary screen, three biological
replicates were used, each containing two technical replicates. We used the same rational as in the
primary screen, and in the end selected hits based on reproducibility.
Controls
Negative controls were used to deﬁne the threshold for hit selection. The positive control was found in a
pilot screen.
Validation of the genetic interactions
In order to conﬁrm the lethality enhancement when the screen hits (‘enhancers’) are depleted in the bmk-
1(ok391) background, we performed a classical embryonic lethality assay14. Brieﬂy, this assay consisted of
feeding wild type (N2) and bmk-1(ok391) (SV1005) L4 worms with HT115 bacteria carrying the RNAi
vector and inducing the expression of dsRNA by IPTG addition (0.5 mM) on agar plates. These worm
strains share the same genetic background as the strains used in the RNAi screen, with the exception that
they do not express any ﬂuorescent marker. 24 h after we started feeding the worms with dsRNA at 20 °C,
we transferred them to new RNAi plates and allowed egg laying for another 24 h, after which the adult
worms were removed. 24 h later embryonic lethality was accessed (Fig. 3a). Several gene knockdowns led
to 100% embryonic lethality (e.g., dli-1, par-6, tbg-1) already in the wild type strain. This suggested that
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the knockdown of these proteins on agar plates was more penetrant than in the liquid format. Because
this precluded us from detecting enhancement of lethality in the bmk-1(ok391) background, we repeated
the embryonic lethality assay on agar plates in two conditions: weak RNAi (0 mM IPTG, resulting in
partial depletion due to basal transcription of dsRNA in the absence of induction) and strong RNAi
(0.5 mM IPTG, corresponding to maximal induction of dsRNA production). We were able to conﬁrm an
increase in embryonic lethality when the selected proteins were partially depleted (0 mM IPTG) in the
bmk-1(ok391) background (Fig. 3b).
Interestingly, 50% of the hits did not show any embryonic lethality when dsRNA was delivered by
feeding on plates (Fig. 3a). We reasoned that they were selected as hits in the screen because the
depletions caused a signiﬁcant delay in larval development in the bmk-1(ok391) background relative to
controls. As the automated analysis counted the number of progeny based on the size of their pharynxes,
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Figure 3. RNAi screen validation. (a) Embryonic lethality assay with the screen's ‘enhancers’. N2 (blue), wild
type strain. SV1005 (red), bmk-1(ok391) deletion strain. RNAi for bmk-1 was used as a negative control. Error
bars represent SEM of three technical replicates. Top graph shows embryonic lethality and below the
corresponding reproductive ﬁtness (expressed in number of live progeny per parent). (b) Embryonic lethality
assay upon weak (0 mM IPTG) or strong (0.5 mM IPTG) depletion of screen ‘enhancers’. Bars represent
averages of two technical replicates.
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larvae with small pharynxes would remain undetected, lowering the reproductive ﬁtness ratio. To test
this hypothesis, we repeated the RNAi-mediated depletion of these proteins by feeding on plates and
classiﬁed the phenotype of larval progeny 3 days after removal of the parent. For 14 out of 38 bacterial
clones, we observed enhanced growth defects in the bmk-1(ok391) background (Table 1). We conclude
that the genetic interactions uncovered in this screen include genes with roles in post-embryonic
development.
Usage Notes
The RNAi screen data (Data Records 1–2) are provided for users to be able to apply their own
normalisation strategies and thresholds for identifying differences between the two strains. This study
focused on genes that when depleted enhanced the lethality in the worm kinesin-5 mutant bmk-1(ok391)
when compared with the control strain. However, some genes showed decreased lethality when depleted
in the bmk-1(ok391) background. These genes are also potential interactors of kinesin-5. Furthermore,
several dsRNAs led to a signiﬁcant developmental delay speciﬁcally in the bmk-1(ok391) background,
which may indicate a function of kinesin-5 during development. The results obtained in this screen
can be compared with data from previous RNAi screens in Caenorhabditis elegans as reported in
RNAiDB (ref. 15).
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